Loading...
Hits identified in library screening demonstrate selective CYP17A1 lyase inhibition.
Krug, Sebastian J Hu, Qingzhong Hartmann, Rolf W
Krug, Sebastian J
Hu, Qingzhong
Hartmann, Rolf W
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2013-03
Submitted date
Files
Loading...
original manuscript
Adobe PDF, 319.94 KB
Other Titles
Abstract
A screening of structurally different steroid hormone synthesis inhibitors was performed in order to find a starting point for the development of a new inhibitor of the bifunctional steroidogenic enzyme CYP17A1. Emphasis was placed on determination of selectivity between the two catalytic steps, namely 17α-hydroxylase and C(17,20)-lyase. For that purpose a new inhibition assay has been developed. Hits identified within this novel assay demonstrated selective inhibition of CYP17A1 lyase activity, and thus mark the basis for the development of selective C(17,20)-lyase inhibitors for the treatment of prostate cancer.
Citation
Hits identified in library screening demonstrate selective CYP17A1 lyase inhibition. 2013, 134:75-9 J. Steroid Biochem. Mol. Biol.
Publisher
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
1879-1220
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
License
Archived with thanks to The Journal of steroid biochemistry and molecular biology